TP53 and neoplasm: Lee et al. (11) have convincingly demonstrated that tissue from the tumor-free SVZ of IDH-wild type GBM patients contained low-level GBM driver mutations (in TP53, PTEN or EGFR), that were found in the dominant clones of its matching tumors (11).